Memorial Sloan Kettering Cancer Center A Multidisciplinary Approach to Thoracic Pathology with Clinical, Molecular and Radiologic Correlations 2021
Overview
24 videos + 25 pdfs, size: 10 GB
Information:
Friday, October 15, 2021, 7:45 AM – Saturday, October 16, 2021, 3:30 PM EST
This two-day live virtual course is designed to give a current review of thoracic pathology with clinical and radiologic correlations. The course will consist of a series of presentations with some multidisciplinary sessions regarding lung cancer, interstitial lung disease and non-neoplastic lung disease.
The new 2021 WHO Classification of Lung Tumors, the 8thEdition TNM Staging Classification, and ATS/ERS Classification of Idiopathic Interstitial Pneumonias will be presented. Most of the speakers will be expert lung pathologists, but there will also be clinical and radiologic presentations by well-known thoracic clinicians and radiologists for the interstitial lung disease topic. The presentations will illustrate the importance of a multidisciplinary approach to solving difficult problems in thoracic disease.
Who Should Attend
This course will be invaluable for pathologists, pulmonologists, thoracic surgeons, and radiologists, including physicians in training.
- Ability to grasp current concepts in lung, pleural and mediastinal pathology
- Understand the importance of correlation between clinical, radiologic and pathologic data in diagnosis and management of interstitial lung disease and pulmonary vasculitis
- Know the significance of lung biopsy and multidisciplinary correlation for the diagnosis of non-neoplastic lung disease with a focus on interstitial pneumonias.
- Comprehend the most recent histologic concepts in lung cancer diagnosis and classification including problematic issues related to spiral CT screening
- Realize the important issues in molecular targeted therapy for lung adenocarcinoma
- Have a practical understanding of differential diagnosis for mediastinal and pleural lesions
- Understand the usefulness of cytology in pulmonary, pleural and mediastinal diagnoses
List of Topics:
Acute Lung Injury with Emphasis on COVID-19 and Vaping.mp4
Acute Lung Injury with Emphasis on COVID-19 and Vaping.pdf
Clinical.mp4
Clinical.pdf
Diagnosis of Lung Cancer in Small Biopsies and Cytology.mp4
Diagnosis of Lung Cancer in Small Biopsies and Cytology.pdf
Guidelines for Diagnosis of Hypersensitivity Pneumonitis.mp4
Guidelines for Diagnosis of Hypersensitivity Pneumonitis.pdf
Immunohistochemistry for Lung Cancer Diagnosis.mp4
Immunohistochemistry for Lung Cancer Diagnosis.pdf
Immunohistochemistry for Predictive Biomarkers in Lung Cancer.mp4
Immunohistochemistry for Predictive Biomarkers in Lung Cancer.pdf
Introduction to the WHO Classification of Lung Cancer.mp4
Introduction to the WHO Classification of Lung Cancer.pdf
Mediastinal Tumors.mp4
Mediastinal Tumors.pdf
Mystery Cases.mp4
Mystery Cases.pdf
Neuroendocrine Tumors of the Lung.mp4
Neuroendocrine Tumors of the Lung.pdf
Pathology of Lung Transplantation.mp4
Pathology of Lung Transplantation.pdf
Pathology of Pulmonary Hypertension.mp4
Pathology of Pulmonary Hypertension.pdf
Pathology.mp4
Pathology.pdf
Pitfalls in Thoracic Frozen Section Diagnosis.mp4
Pitfalls in Thoracic Frozen Section Diagnosis.pdf
Pleural Tumors of the Lung.mp4
Pleural Tumors of the Lung.pdf
Problem Cases in Diagnosis of Interstitial Lung Disease.mp4
Problem Cases in Diagnosis of Interstitial Lung Disease.pdf
Pulmonary Infections.mp4
Pulmonary Infections.pdf
Radiology.mp4
Radiology.pdf
Sarcomatoid Carcinomas of the Lung.mp4
Sarcomatoid Carcinomas of the Lung.pdf
Staging of Lung Cancer.mp4
Staging of Lung Cancer.pdf
The Pathologist’s Role in Multidisciplinary Discussion for ILD.mp4
The Pathologist’s Role in Multidisciplinary Discussion for ILD.pdf
Therapeutically Relevant Molecular Subsets of Lung Cancer.mp4
Therapeutically Relevant Molecular Subsets of Lung Cancer.pdf
ThoracicPath2021Digital2.pdf
Unusual Tumors of the Lung.mp4
Unusual Tumors of the Lung.pdf
Variants of Lung Adenocarcinoma and Squamous Cell Carcinoma.mp4
Variants of Lung Adenocarcinoma and Squamous Cell Carcinoma.pdf